semaglutide news today 2025 Hims & Hers to offer generic in Canada as Novo Nordisk patent lapses – NBC Bay Area Study suggests new drug for

ranges from $1,200 to $1,400 per month

For patients hesitant about injections or seeking an alternative, the pill may be a welcome development

Do not report a BMI code without a supporting physician-documented diagnosis (obesity, overweight, or underweight)

Tirzepatide at the highest dose produced even more dramatic results, with average weight loss reaching 20.2% in the SURMOUNT-5 trial

Inositol (25-50 mg per mL): a carbocyclic sugar alcohol classified as part of the B-vitamin complex

What Experts and Scientists Are Actually Saying Coverage of this topic has been heavy on political narrative and light on the underlying scientific debate